Stock comparison

RDYvsSNY

Dr. Reddy's Laboratories Limited American Depositary SharesvsSanofi American Depositary Shares (Each representing one-half of one ordinary share). Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

RDY

Dr. Reddy's Laboratories Limited American Depositary Shares

$13.67

-2.98%

HealthcareDrug Manufacturers - Specialty & Generic$11.9B
SNY

Sanofi American Depositary Shares (Each representing one-half of one ordinary share)

$46.78

-2.91%

HealthcareDrug Manufacturers - General$111.6B

60-day price, rebased to 100

RDY +3.01% · SNY -2.70%

Round-by-round

RDY 3·SNY 2· 1tie
EdgeRDY

Valuation upside

+7281.00% vs +32.00% to DCF fair value

EdgeRDY

Balance-sheet strength

Altman Z 2.38 vs 1.86

EdgeSNY

Fundamental quality

Piotroski 3.00 vs 7.00 (of 9)

Tie

Growth + margins

Rule-of-40 20.30 vs 20.90

EdgeRDY

60-day momentum

+3.01% vs -2.70% price return

EdgeSNY

Market-cap liquidity

$11.9B vs $111.6B

Verdict

Across6categories,RDYtakes the edge with3wins to2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onRDYorSNY

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.

For informational and educational purposes only. Not financial advice. Learn more